Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price lifted by Benchmark from $81.00 to $96.00 in a report released on Thursday, The Fly reports. EXAS has been the topic of a number of other reports. Credit Suisse Group restated a neutral rating and set a $70.00 price target on shares of Exact Sciences […]
1-800-FLOWERS.COM restated their reiterates rating on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report released on Thursday morning, Benzinga reports. Other equities analysts have also issued research reports about the company. BTIG Research boosted their price objective on Exact Sciences from $95.00 to $110.00 in a research note on Thursday. Cowen […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective raised by Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. EXAS has been the subject of a number of other reports. Craig Hallum upgraded shares of Exact Sciences from a hold rating to a buy rating […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target boosted by Stifel Nicolaus from $85.00 to $120.00 in a report released on Thursday, The Fly reports. A number of other research analysts have also recently commented on the stock. Piper Sandler increased their price target on shares of Exact Sciences from $70.00 to $80.00 […]
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price increased by analysts at Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. Benchmark’s target price indicates a potential upside of 3.65% from the stock’s previous close. Several other analysts have also recently issued reports on the […]